Melioidosis is the stuff of tragedy. The bacterium that causes it can affect different organs in different people, throwing off doctors and leading to misdiagnosis and death.
Notwithstanding the recent unpredictability seen in Indian influenza seasons, we know that flu has become enough of a threat to warrant a vaccination policy.
The dilly-dallying by ministries over their financial commitments is a sign that they are still wary of making the leap from academic research to product development.
Himanshu Bansal wants to perform an experiment that will revive brain-dead people. However, he may have skipped some regulations while his previous research raises serious ethical and scientific questions.
Indian researchers can and will eventually develop high-yielding mustard hybrids through non transgenic means. Still, India will need transgenic mustard as an alternative.
One reason to expect the three genes used in transgenic mustard to be safe is that they aren’t new at all. They have been in the human food-chain for around two decades now.
Bharat Biotech claims it can introduce a Zika vaccine in two years, but given the challenges involved in actually developing a vaccine and regulatory hurdles, is the estimate too hopeful?
Can there ever be legitimacy in quackery?